Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maternal immunization.

W P Glezen1, M Alpers

  • 1Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Texas 77030, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|March 4, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influenza surveillance in an urban area.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Maternal immunization with Haemophilus influenzae type b vaccines in different populations.

Vaccine·2003
Same author

Epidemiology and molecular characterization of co-circulating influenza A/H3N2 virus variants in children: Houston, Texas, 1997-8.

Epidemiology and infection·2003
Same author

Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation.

Vaccine·2001
Same author

Maternal vaccines.

Primary care·2001
Same author

A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease.

The Pediatric infectious disease journal·2001
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Low Post-Treatment Recurrence After a Shortened All-oral Regimen for Pulmonary Rifampicin- or Multidrug-Resistant Tuberculosis in Individuals without Prior Second-Line Drug Exposure in Kazakhstan.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Sepsis Diagnostic Excellence and its Association with Mortality in Adults with Potential Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Maternal immunization during pregnancy protects both mothers and infants from serious diseases. Ideally, vaccines should be given at least six weeks before delivery for optimal infant protection.

Area of Science:

  • Immunology
  • Public Health
  • Obstetrics

Background:

  • Maternal immunization offers a strategy to protect infants from life-threatening pathogens before they can be vaccinated.
  • Vaccination during pregnancy provides dual benefits, protecting the pregnant individual and their offspring.

Purpose of the Study:

  • To review the benefits and considerations of maternal immunization for infant and maternal protection.
  • To highlight vaccines currently available and under evaluation for use in pregnancy.

Main Methods:

  • Review of existing literature on maternal immunization, placental antibody transfer, and vaccine safety in pregnancy.
  • Analysis of vaccine efficacy and timing for optimal passive immunity transfer.

Main Results:

Related Experiment Videos

  • Maternal immunization with vaccines like tetanus toxoid and influenza provides protection to both mother and infant.
  • Vaccines for respiratory syncytial virus, pneumococci, group B streptococci, and Haemophilus influenzae type b are under evaluation.
  • Optimal antibody transfer occurs in the third trimester, recommending immunization at least six weeks before delivery.
  • Maternal immunization does not interfere with infant active immunization schedules.
  • Inactivated vaccines in the third trimester are safe for both mother and fetus.

Conclusions:

  • Maternal immunization is a safe and effective strategy for enhancing infant immunity against severe diseases.
  • Strategic timing of maternal vaccination is crucial for maximizing passive antibody transfer to the fetus.
  • Continued research and development of maternal vaccines are essential for improving infant and maternal health outcomes.